Home › Aortic Valve Disease › NCT04754217

Valved Graft PMCF Study

RecruitingObservational study

Valved Graft Post-Market Clinical Follow-up Study

Who can join

Ages 18 and older · All sexes

Full eligibility criteria

Inclusion Criteria:

* cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthetic valve replacement

Exclusion Criteria:

* anticoagulation therapy intolerant
* active endocarditis
* anatomical or medical, surgical, psychological or social contraindications

About the study

Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.

What is being tested

VAVGJ (device)
CAVGJ (device)

Sponsor: Abbott Medical Devices · Participants: 260 · Started: Jul 13, 2021

Contact the study team

Paolo Amato · Phone: +39 335 61 40 573
Karine Miquel · Phone: +32 479 60 01 07

Official record on ClinicalTrials.gov — NCT04754217

Locations in the U.S.

Michigan	University of Michigan, Ann Arbor
Pennsylvania	Hospital of the University of Pennsylvania, Philadelphia University of Pittsburgh Medical Center, Pittsburgh

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.